Micro-RNA compound found suitable for further development following favorable pharmacokinetic and pharmacodynamic study results CAMBRIDGE, England & BUDAPEST, Hungary–(BUSINESS WIRE)–Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, and Pharmahungary Group, […]